Bender Robert & Associates
- SEC CIK
- 0000894300
- Latest filing
- Jul 30, 2026
SMMT holding history
Summit Therapeutics Inc. in every 13F filed by Bender Robert & Associates, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SMMT overviewAll 13F holders of SMMTFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −11,496−100.0% | Sold out | Holders |
| Q4 2024 | 11,496 | $205.1K | <0.1% | +11,496 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −24,059−100.0% | Sold out | Holders |
| Q4 2023 | 24,059 | $62.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 24,059 | $45.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 24,059 | $60.4K | <0.1% | +10,000+71.1% | Added | Holders |
| Q1 2023 | 14,059 | $24.6K | <0.1% | +14,059 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −14,059−100.0% | Sold out | Holders |
| Q3 2022 | 14,059 | $17.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 14,059 | $14.0K | <0.1% | +14,059 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −14,059−100.0% | Sold out | Holders |
| Q1 2021 | 14,059 | $83.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.